Topic: pets


Zoetis wins approval for monthly flea-fighting pill

Zoetis won FDA approval on Feb. 25 for Simparica (sarolaner), a once-monthly chewable pill that fends off fleas and four types of ticks, setting up a three-way race between Zoetis, Merck Animal Health and Sanofi's Merial to capture a global market for antiparasitics that consultant Vetnosis estimates to be worth more than $4 billion a year.

Scientists pinpoint contributions pets can make to human medicine

Last June, the National Academies' Institute of Medicine hosted a two-day workshop in Washington, DC, aimed at promoting clinical research in dogs that can be translated to finding new cures for people. Now the IOM is sharing insights that came from the more than 20 veterinarians and scientists who attended the event.